Intermittent versus Daily Eltrombopag Dosage Protocols for the Treatment of Primary Immune Thrombocytopenia: Real-Life Experience

INTRODUCTION/AIM: Eltrombopag is recommended for the treatment of refractory immune thrombocytopenia (ITP). Based on its half-life, it may be practical to use an intermittent dosage. Our aim was to compare the effectiveness and safety of intermittent vs daily eltrombopag dosage protocols for the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbedewy, Tamer A, Elsebaey, Mohamed A, Elkholy, Reem A, Tahoon, Dina M, Elshweikh, Samah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783199/
https://www.ncbi.nlm.nih.gov/pubmed/33414648
http://dx.doi.org/10.2147/JBM.S289149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783199/
https://www.ncbi.nlm.nih.gov/pubmed/33414648
http://dx.doi.org/10.2147/JBM.S289149

Ejemplares similares